All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC1303 | Human anti-UL83 T cell receptor (10), pCDTCR1 | HCMV | 10 | Human | CPSQEPMSIYVY | HLA-B*35:08 | Lentiviral vector | |
TCR-YC1304 | Human anti-UL83 T cell receptor (12), pCDTCR1 | HCMV | 12 | Human | EDVPSGKLFMHVTLG | HLA class II | Lentiviral vector | |
TCR-YC1305 | Human anti-UL83 T cell receptor (13), pCDTCR1 | HCMV | 13 | Human | ARNLVPMVATVQGQN | HLA class II | Lentiviral vector | |
TCR-YC1306 | Human anti-UL83 T cell receptor (A18), pCDTCR1 | HCMV | A18 | Human | IDLLLQRGPQYSEHPTFTSQYRI | HLA-A*01:01 | Lentiviral vector | |
TCR-YC1307 | Human anti-UL83 T cell receptor (B20), pCDTCR1 | HCMV | B20 | Human | PPWQAGILARNLVPMVATVQGQN | HLA-A*02:01 | Lentiviral vector | |
TCR-YC1308 | Human anti-UL83 T cell receptor (B3), pCDTCR1 | HCMV | B3 | Human | IDLLLQRGPQYSEHPTFTSQYRI | HLA-A*01:01 | Lentiviral vector | |
TCR-YC1309 | Human anti-UL83 T cell receptor (k 1), pCDTCR1 | HCMV | k 1 | Human | CPSQEPMSIYVY | HLA-B*35:08 | Lentiviral vector | |
TCR-YC1310 | Human anti-UL83 T cell receptor (k 2), pCDTCR1 | HCMV | k 2 | Human | CPSQEPMSIYVY | HLA-B*35:08 | Lentiviral vector | |
TCR-YC1311 | Human anti-UL83 T cell receptor (r2β6), pCDTCR1 | HCMV | r2β6 | Human | CPSQEPMSIYVY | HLA-B*35:08 | Lentiviral vector | |
TCR-YC1312 | Human anti-UL83 T cell receptor (r6β), pCDTCR1 | HCMV | r6β | Human | CPSQEPMSIYVY | HLA-B*35:08 | Lentiviral vector | |
TCR-YF322 | Human anti-UL83 T cell receptor (BV16), pCDTCR1 | Virus | BV16 | Human | NLVPMVATV | HLA-A2 | Lentiviral vector | |
TCR-YF323 | Human anti-UL83 T cell receptor (BV8), pCDTCR1 | Virus | BV8 | Human | NLVPMVATV | HLA-A2 | Lentiviral vector | |
TCR-YF324 | Human anti-UL83 T cell receptor (C40), pCDTCR1 | Virus | C40 | Human | NLVPMVATV | HLA-A*02:01 | Lentiviral vector | |
TCR-YF325 | Human anti-UL83 T cell receptor (D12), pCDTCR1 | Virus | D12 | Human | NLVPMVATV | HLA-A2 | Lentiviral vector | |
TCR-YF326 | Human anti-UL83 T cell receptor (KEL-12), pCDTCR1 | Virus | KEL-12 | Human | NLVPMVATV | HLA-A*0201 | Lentiviral vector | |
TCR-YF329 | Human anti-UL83 T cell receptor (CD40-29), pCDTCR1 | CMV | CD40-29 | Human | TPRVTGGGAM | HLA-B*0702 | Lentiviral vector | |
TCR-YF331 | Human anti-UL83 T cell receptor (AM41), pCDTCR1 | CMV | AM41 | Human | TPRVTGGGAM | HLA-B*0702 | Lentiviral vector | |
TCR-YF332 | Human anti-UL83 T cell receptor (UA1), pCDTCR1 | Virus | UA1 | Human | NLVPMVATV | HLA-A*02:01 | Lentiviral vector | |
TCR-YF333 | Human anti-UL83 T cell receptor (UB9), pCDTCR1 | Virus | UB9 | Human | NLVPMVATV | HLA-A*02:01 | Lentiviral vector | |
TCR-YF334 | Human anti-UL83 T cell receptor (VA8), pCDTCR1 | Virus | VA8 | Human | NLVPMVATV | HLA-A*02:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION